Remarkably, spns2 deletion in mice, whether globally or in a lymphatic endothelial-specific manner, leads to improved tumor killing and significantly decreased metastatic burden in Spns2−/− mice as a result of increased levels of natural killer cells and effector T cells [118]. This evidence concerns the gene SPNS2 and neoplasm.